EAM
Erste Asset Management Portfolio holdings
AUM
$11.9B
1-Year Return
22.95%
This Quarter Return
+8.41%
1 Year Return
+22.95%
3 Year Return
+112.82%
5 Year Return
+205.55%
10 Year Return
–
AUM
$5.55B
AUM Growth
+$502M
(+9.9%)
Cap. Flow
+$203M
Cap. Flow
% of AUM
3.66%
Top 10 Holdings %
Top 10 Hldgs %
19.68%
Holding
934
New
51
Increased
198
Reduced
144
Closed
33
Top Buys
| 1 |
Cintas
CTAS
|
+$23.7M |
| 2 |
Sunrun
RUN
|
+$18.3M |
| 3 |
Agios Pharmaceuticals
AGIO
|
+$14.6M |
| 4 |
NOVA
Sunnova Energy
NOVA
|
+$14M |
| 5 |
Home Depot
HD
|
+$13.5M |
Top Sells
| 1 |
Silicon Motion
SIMO
|
+$25.9M |
| 2 |
NVIDIA
NVDA
|
+$25.7M |
| 3 |
Visa
V
|
+$16.9M |
| 4 |
Comcast
CMCSA
|
+$16.5M |
| 5 |
TJX Companies
TJX
|
+$14.5M |
Sector Composition
| 1 | Technology | 31.13% |
| 2 | Healthcare | 18.95% |
| 3 | Consumer Discretionary | 13.96% |
| 4 | Financials | 9.3% |
| 5 | Industrials | 7.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
351
Ametek
AME
$43.6B
| $988K | 0.02% |
6,700
-352
| -5% | -$51.9K |
|
352
iShares MSCI ACWI ETF
ACWI
$22.3B
| $985K | 0.02% |
9,295
-1,442
| -13% | -$153K |
|
353
Progyny
PGNY
$1.96B
| $972K | 0.02% |
18,628
+9,550
| +105% | +$498K |
|
354
TC Energy
TRP
$53.9B
| $954K | 0.02% |
20,200
+5,500
| +37% | +$260K |
|
355
Adaptive Biotechnologies
ADPT
$1.91B
| $937K | 0.02% |
35,700
| – | – |
|
|
KRTX
356
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $932K | 0.02% |
7,070
| – | – |
|
|
SPLK
357
DELISTED
Splunk Inc
SPLK
| $924K | 0.02% |
8,000
| – | – |
|
358
Mondelez International
MDLZ
$80.1B
| $923K | 0.02% |
13,985
+9,216
| +193% | +$608K |
|
359
Autoliv
ALV
$9.74B
| $922K | 0.02% |
9,018
+3,050
| +51% | +$312K |
|
360
Pacira BioSciences
PCRX
$1.2B
| $896K | 0.02% |
14,400
| – | – |
|
361
Bright Horizons
BFAM
$6.62B
| $893K | 0.02% |
7,133
+3,400
| +91% | +$426K |
|
|
DCBO
362
Docebo
DCBO
$913M
| $890K | 0.02% |
13,300
+6,800
| +105% | +$455K |
|
363
Ball Corp
BALL
$13.9B
| $886K | 0.02% |
9,300
+7,100
| +323% | +$676K |
|
364
Franco-Nevada
FNV
$38B
| $885K | 0.02% |
6,530
+3,400
| +109% | +$461K |
|
365
GeoPark
GPRK
$317M
| $882K | 0.02% |
80,000
| – | – |
|
366
STAAR Surgical
STAA
$1.37B
| $881K | 0.02% |
9,503
+5,685
| +149% | +$527K |
|
|
TPTX
367
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $876K | 0.02% |
18,700
| – | – |
|
368
DexCom
DXCM
$30.6B
| $869K | 0.02% |
6,492
+2,660
| +69% | +$356K |
|
369
Stride
LRN
$7.17B
| $859K | 0.02% |
26,100
+11,000
| +73% | +$362K |
|
370
Kura Oncology
KURA
$707M
| $850K | 0.02% |
58,000
| – | – |
|
371
United Natural Foods
UNFI
$1.74B
| $825K | 0.01% |
16,144
+1,800
| +13% | +$92K |
|
|
BCYC
372
Bicycle Therapeutics
BCYC
$485M
| $822K | 0.01% |
+14,000
| New | +$822K |
|
373
Zentalis Pharmaceuticals
ZNTL
$118M
| $818K | 0.01% |
9,800
| – | – |
|
374
BridgeBio Pharma
BBIO
$10.4B
| $812K | 0.01% |
57,225
| – | – |
|
375
Arch Capital
ACGL
$33.9B
| $807K | 0.01% |
18,100
-3,400
| -16% | -$152K |
|